BAG1 and breast carcinoma: BAG-1 potentiates activity of oestrogen receptors (ER) (R Cutress, PA Townsend and G Packham, unpublished data), which mediates proliferative, and survival responses to oestrogens in hormone dependent breast cancers and is the target for anti-hormone therapies such as tamoxifen.